RXMD had annual revenue just under $50 million in 2023.
Value given in the deal with NXPL: roughly $10 million I believe.
Had there been an ounce of effort to support RXMD shareholder value after Fernandez invested, he wouldn't have been able to pull this merger at the ridiculous terms.
This is why the mentions of a class action lawsuit have heated up.